JEFFREY SUMME: Open Payments
NPI 1861409732 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 20 payments from 6 companies in 2025. Trend: 2023 $1,201 · 2024 $511 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Orexo US, Inc. | 11 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Zubsolv, RELISTOR, TRULANCE, FARXIGA, LINZESS, SAPIEN 3 Ultra RESILIA, Wegovy.
Industry payments across WA — which companies pay providers there.
